The management of essential hypertension.
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D003647:Debrisoquin / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D010425:Pentolinium Tartrate / Q000627:therapeutic use; D011187:Posture; D011433:Propranolol / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D006113:United Kingdom
D000959:Antihypertensive Agents; D001593:Benzyl Compounds; D004232:Diuretics; D006146:Guanidines; D049993:Sodium Chloride Symporter Inhibitors; D013431:Sulfates; D008750:Methyldopa; D010425:Pentolinium Tartrate; D011433:Propranolol; D003981:Diazoxide; D003647:Debrisoquin